Cost effectiveness of strategies to combat HIV / AIDS in developing countries.

Harvard University, Cambridge, Massachusetts, United States
BMJ (online) (Impact Factor: 16.38). 01/2006; 331(7530):1431-7. DOI: 10.1136/bmj.38643.368692.68
Source: PubMed

ABSTRACT To assess the costs and health effects of a range of interventions for preventing the spread of HIV and for treating people with HIV/AIDS in the context of the millennium development goal for combating HIV/AIDS.
Cost effectiveness analysis based on an epidemiological model.
Analyses undertaken for two regions classified using the WHO epidemiological grouping-Afr-E, countries in sub-Saharan Africa with very high adult and high child mortality, and Sear-D, countries in South East Asia with high adult and high child mortality.
Biological and behavioural parameters from clinical and observational studies and population based surveys. Intervention effects and resource inputs based on published reports, expert opinion, and the WHO-CHOICE database.
Costs per disability adjusted life year (DALY) averted in 2000 international dollars (Int dollars).
In both regions interventions focused on mass media, education and treatment of sexually transmitted infections for female sex workers, and treatment of sexually transmitted infections in the general population cost < Int150 dollars per DALY averted. Voluntary counselling and testing costs < Int350 dollars per DALY averted in both regions, while prevention of mother to child transmission costs < Int50 dollars per DALY averted in Afr-E but around Int850 dollars per DALY in Sear-D. School based education strategies and various antiretroviral treatment strategies cost between Int500 dollars and Int5000 dollars per DALY averted.
Reducing HIV transmission could be done most efficiently through mass media campaigns, interventions for sex workers and treatment of sexually transmitted infections where resources are most scarce. However, prevention of mother to child transmission, voluntary counselling and testing, and school based education would yield further health gains at higher budget levels and would be regarded as cost effective or highly cost effective based on standard international benchmarks. Antiretroviral therapy is at least as cost effective in improving population health as some of these interventions.

Download full-text


Available from: Adrian Salomon, Jul 28, 2015
  • Source
    • "Advanced HIV (AIDS) is a phenomenon that its social, cultural and economic aspects are very broad. In June 2000 in the United Nation Security Council (UNSC) Resolution it was recognized as a potential threat to global stability and security for the first time (Hogan et al., 2005). AIDS is now the fourth cause of human mortality and is predicted to be the first by 2020. "
    Scientific research and essays 01/2012; 7(6):693-697. · 0.45 Impact Factor
  • Source
    • "In countries with widespread HIV/AIDS epidemics, there is an ongoing debate as to whether preventative interventions, such as mass media and school education, condom provision for sex workers and others, and voluntary counseling and testing services, are preferable to treatment, in the form of antiretroviral therapies (ARVs) – see for example, Creese et al. (2002), Hogan et al. (2005), and Canning (2006). This debate continues even though it is well known that the prevention/treatment choice, firstly, excludes a third option, mitigation, as with caring for AIDS orphans and, secondly, this choice is not mutually exclusive, seeing that people often get involved with prevention only when treatment is possible and available. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This article uses the revealed preference approach to estimate the price for a Disability Adjusted Life Year (DALY) implied by grant decisions by the Global Fund for AIDS, tuberculosis (TB) and malaria (GFATM). A cost-benefit criterion is used that requires the DALY price exceed the cost-effectiveness ratio. The estimated price was $6300 for a DALY saved from any disease, but it was $11 900 from a DALY saved specifically from HIV/AIDS. Estimates of the cost-effectiveness ratios of Antiretroviral Drug Therapies (ARVs) in the literature were examined. At the DALY prices implicit by GFATM decisions, ARVs would be socially worthwhile.
    Applied Economics 04/2011; 43(11):1413-1421. DOI:10.1080/00036840802600475 · 0.46 Impact Factor
  • Source
    • "Ironically, HIV/AIDS has been heavily researched, resulting in numerous publications that detail effective prevention interventions. The list of effective HIV/AIDS prevention strategies includes prevention of mother-to-child transmission, sex education and treatment of sexually transmitted infections, voluntary counseling and testing, interventions for sex workers, school based education programs (Hogan et al., 2005), needle exchange programs (Sinding, 2005), condom use (Morris & Ferguson, 2006), and a reduction in the number of sexual partners (Green, Halperin, Nantulya, & Hogle, 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The President’s Emergency Plan for AIDS Relief (PEPFAR) is the most recent international social program instituted by the U.S. Government to combat HIV/AIDS. Since its inception in 2003, this foreign policy initiative has provided $15 billion for HIV/AIDS prevention and treatment in 15 focus countries. Despite PEPFAR’s many accomplishments, it continues to promote controversial prevention strategies. This paper analyzes these prevention strategies, utilizing social work values as described in the NASW Code of Ethics. Policy, practice, and research implications are discussed.
    Journal of sociology and social welfare 03/2010; 37(1):9-22.
Show more